Translational Cancer Research is indexed in Scopus

Published: 2015-08-24
Dear readers, 

With pleasure, we are here to announce that Translational Cancer Research (TCR) has been accepted for inclusion in Scopus. Within months, article titles, abstracts, and references of TCR articles will be searchable in Scopus. It is hopefully that more researchers and clinicians would access TCR articles via the Scopus database with the inclusion.  

Scopus is the largest abstract and citation database of peer-reviewed literature, featuring smart tools to track, analyze and visualize research . It is appreciated that the Scopus evaluation team comment on the journal as “a well presented journal with high quality content”. 

Translational Cancer Research (Transl Cancer Res; Print ISSN: 2218-676X; Online ISSN 2219-6803;, is an open access, peer-reviewed journal launched in June 2012. It publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients, aiming to promote a rapid exchange of scientific information between clinicians and scientists worldwide. 

The operation of TCR is driven by the leadership and passion of Editor-in-Chief, Prof. Eric Chuang; co-Editor-in- Chief, Dr. Huan Giap; and Associate Editor-in-Chief, Dr. Binghe Xu. They devote their time and bring their decades of experience in scientific research and publications for managing this journal. TCR has now been published 19 issues including 13 focused issues respectively on topics as followed. 

  • “Particle Beam Therapy I&II” (Huan Giap, Scripps Proton Therapy Center), 
  • “DNA Damage and Repair” (Benjamin P.C. Chen & David J. Chen; U. Texas Southwestern Medical Center at Dallas)
  • “Nanotechnology in Radiation Research” (Rao V. L. Papineni, University of Kansas Medical Center; Pataje G. Prasanna & Mansoor M. Ahmed, National Cancer Institute, National Institutes of Health) 
  • “Stem Cell in Cancer” (Daohong Zhou, University of Arkansas for Medical Sciences; Chuan-Yuan Li, Duke University Medical Center)
  • “Liver cancer” (Catherine T. Frenette, Scripps Center for Organ and Cell Transplantation)
  • “IORT I&II” (Frederik Wenz & Elena Sperk & Frederik Wenz, University of Heidelberg; Pedro Lara, University of Las Palmas)
  • “Statistical and Bioinformatics Applications in Biomedical Omics Research” (Dung-Tsa Chen & Yian Ann Chen, Moffitt Cancer Center)
  • “SBRT/SRS in Radiation Research” (Sandra Vermuelen, Swedish Medical Center; Kevin T. Murphy, University of California; Huan Giap, Scripps Proton Therapy Center,)
  • “High Intensity Focused Ultrasound” (Giusi Irma Forte & Giorgio Russo, 1Istituto di Bioimmagini e Fisiologia Molecolare) 
  • “Epithelial ovarian cancer treatment: integrating molecular targeting” (Franco Muggia and Eleonora Teplinsky, New York University Langone Medical Center)
  • “Application of Genomic Technologies in Cancer Research" (Jian-Bing Fan, PhD, Southern Medical University)
More focused issues on topics respectively of “Lung Cancer”, “Pancreatic Cancer” “Lysophospholipids on Immunity and Cancer”, “"Combinatorial Cancer Therapy- Bench to Personalized Medicine", “Radiation induced cancer”, and “Circulating Tumor Cells” etc. are now proceeding with efforts of The Editors. 

In addition to the coming indexing of titles, abstracts and references in Scopus, TCR owns the OJS system that deal with manuscripts from submission, reviewing to decision making to ensure short term of turnaround vary from one week to 2 months. No article process fee or publication fee is required to publish in TCR. We highly encourage you to submit your manuscripts to TCR.

TCR Editorial Team
Eric Y Chuang, Sc.D, Editor-in-Chief; 
Huan Giap, MD, PhD, MD, co-Editor-in- Chief; 
Binghe Xu, Prof., MD, PhD, Associate Editor-in-Chief;  
Nancy Q. Zhong, Corresponding Editor;
Molly J. Wang, Science Editor; 
Lucille L. Ye, Science Editor.